Claus Torp Jensen - 01 Dec 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
4
Filing time
05 Dec 2023, 16:08:07 UTC
Previous filing
06 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2,807 +18% 18,660 01 Dec 2023 Direct F1
transaction TDOC Common Stock Options Exercise +2,043 +11% 20,703 01 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -2,807 -17% $0.000000 14,038 01 Dec 2023 Common Stock 2,807 Direct F1, F2
transaction TDOC Restricted Stock Units Options Exercise $0 -2,043 -14% $0.000000 12,264 01 Dec 2023 Common Stock 2,043 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Claus Torp Jensen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F3 On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.